Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
108
-
Total shares
-
3.1M
-
Shares change
-
+157K
-
Total reported value, excl. options
-
$282M
-
Value change
-
+$13.2M
-
Put/Call ratio
-
0.58
-
Number of buys
-
47
-
Number of sells
-
-58
-
Price
-
$90.87
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q4 2016
113 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q4 2016.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.1M shares
.
Largest 10 shareholders include MORGAN STANLEY (808K shares), WELLS FARGO & COMPANY/MN (422K shares), UBS Group AG (244K shares), BANK OF AMERICA CORP /DE/ (211K shares), RAYMOND JAMES & ASSOCIATES (129K shares), LPL Financial LLC (108K shares), AMERIPRISE FINANCIAL INC (87.8K shares), ROYAL BANK OF CANADA (84.6K shares), J&P(CHINA)CAPITAL MANAGEMENT CO.,LTD (78.5K shares), and McKinley Carter Wealth Services, Inc. (72.5K shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.